Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients.
Luca BiascoNatalia IzotovaChristine RivatSara GhorashianRachel RichardsonAleks GuvenelRachael HoughRobert WynnBilyana PopovaAndre LopesMartin PuleAdrian J ThrasherPersis Jal AmroliaPublished in: Nature cancer (2021)
Low-affinity CD19 chimeric antigen receptor (CAR) T cells display enhanced expansion and persistence, enabling fate tracking through integration site analysis. Here we show that integration sites from early (1 month) and late (>3yr) timepoints cluster separately, suggesting different clonal contribution to early responses and prolonged anti-leukemic surveillance. CAR T central and effector memory cells in patients with long-term persistence remained highly polyclonal, whereas diversity dropped rapidly in patients with limited CAR T persistence. Analysis of shared integrants between the CAR T cell product and post-infusion demonstrated that, despite their low frequency, T memory stem cell clones in the product contributed substantially to the circulating CAR T cell pools, during both early expansion and long-term persistence. Our data may help identify patients at risk of early loss of CAR T cells and highlight the critical role of T memory stem cells both in mediating early anti-leukemic responses and in long-term surveillance by CAR T cells.
Keyphrases
- stem cells
- working memory
- acute myeloid leukemia
- public health
- end stage renal disease
- induced apoptosis
- chronic kidney disease
- cell therapy
- low dose
- dendritic cells
- oxidative stress
- immune response
- cell proliferation
- deep learning
- cell cycle arrest
- cell death
- machine learning
- bone marrow
- regulatory t cells
- electronic health record
- big data